Goldman Sachs’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98.6K Sell
94,848
-74,097
-44% -$72.3K ﹤0.01% 6338
2026
Q1
$114K Sell
168,945
-330,459
-66% -$271K ﹤0.01% 6187
2025
Q4
$454K Sell
499,404
-534,173
-52% -$512K ﹤0.01% 5649
2025
Q3
$922K Buy
1,033,577
+666,493
+182% +$970K ﹤0.01% 5080
2025
Q2
$793K Buy
367,084
+201,640
+122% +$731K ﹤0.01% 4864
2025
Q1
$796K Sell
165,444
-18,199
-10% -$104K ﹤0.01% 4855
2024
Q4
$1.18M Buy
+183,643
New +$894K ﹤0.01% 4691
2017
Q4
Sell
-468
Closed -$84K 6542
2017
Q3
$84K Buy
+468
New +$112K ﹤0.01% 6122

Other funds holding MYO

Goldman Sachs's MYO Position: Q2 2026 in Review

Goldman Sachs reduced its Myomo (MYO) stake by 44% in Q2 2026, selling an estimated $72.3K and leaving 94,848 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6338.

Goldman Sachs first reported a position in MYO in Q3 2017 and has held it in 8 quarters since. The position peaked at $1.18M in Q4 2024. 80 funds tracked by Wall St. Rank hold MYO as of Q2 2026.

  • Goldman Sachs held 94,848 shares of Myomo worth $98.6K as of Q2 2026.
  • Goldman Sachs sold 74,097 Myomo shares in Q2 2026, an estimated $72.3K.
  • Myomo made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6338 holding.
  • Goldman Sachs first reported a position in Myomo in Q3 2017 and has held it in 8 quarters since.
  • Goldman Sachs's Myomo position peaked at $1.18M in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.